We look for partnerships that will help us to continue offering the best solutions for skin health. We have a dedicated alliance structure in each business to maximize this collaborative work and can commit resources so that your innovation fulfils its true potential.
Consumer skin care opportunities
Our leading brands such as Cetaphil and Proactiv are top players in consumer skin care and have global geographical footprints. They are dedicated to answer the multiple skin care needs of sensitive skin and acne sufferers with innovation at the heart of their growth models. As such, we are constantly looking at a wide range of opportunities that are relevant from a consumer perspective as well as endorsed by healthcare professionals. These opportunities can range from technologies or ingredients to finished products or solutions whatever development stage they are at.
Contact us: [email protected]
Prescription product opportunities
We look for innovative compounds we can develop and commercialize as products that may provide breakthrough therapies for dermatological conditions and unmet needs. Our scope of interest includes small and large molecules, with a focus on systemic orals and biologics, though we will consider all routes of administration.
Our priority disease targets include immune-mediated inflammatory skin diseases - primarily atopic dermatitis and psoriasis. However, we are also interested in opportunities to bring therapeutic value in targeting other skin diseases, such as non-melanoma skin cancers and rare dermatological diseases.
We have the capabilities to onboard a partnered compound or product at any stage and therefore are open to consider pre-clinical, clinical or commercial-stage assets.
Contact us: [email protected]
Galderma Aesthetics opportunities
We are a pioneer, and one of the top players globally, in medical aesthetics. Our portfolio has a strong medical and scientific basis and is present in more than 100 countries. We are always looking to support innovation which improves the possibilities for medical solutions and services in the minimally invasive aesthetics field. These could be ingredients, formulations, technologies or devices, from early research to commercially available solutions and products.
Contact us: [email protected]